Russia ready to boost anti-terror cooperation with Asia-Pacific countriesMilitary & Defense October 24, 11:52
Russia expected to jump above 40th spot in Doing Business ranking in 2017Business & Economy October 24, 11:50
Ukrainian police take nationalists into custody for blocking Kiev courtWorld October 24, 11:41
Siberian scientists work on communication technology for ArcticBusiness & Economy October 24, 11:20
Cyprus president praises bilateral relations with RussiaWorld October 24, 11:13
Russia ready to boost dialogue with ASEAN — defense ministerRussian Politics & Diplomacy October 24, 10:46
IS terrorists control less than 5% of Syria’s territory — Russian defense ministerMilitary & Defense October 24, 9:53
Russian tennis star Sharapova provides humanitarian aid to hurricane-hit Puerto RicoSport October 24, 9:39
CBP: Hermitage Capital’s Browder has right to enter USWorld October 24, 3:56
GENEVA, October 2. /TASS/. The World Health Organization (WHO) on Wednesday published new data, in line with which the death toll from the Ebola virus outbreak has reached 3,338 people out of a total of 7,178 officially registered cases.
The WHO report says the epidemic spread has slowed down for a second week. At the same time, the global health body warned that some cases could be underreported. The figures are cited as of the end of last week, September 28.
The Ebola virus disease (EVD), previously known as the Ebola hemorrhagic fever, is a severe illness in humans, often fatal, according to the WHO website. The virus is passed on to people from wild animals and can be transmitted from humans to humans. The average EVD case death rate is some 50%
The first outbreaks of the EVD occurred in remote Central African villages, near tropical rainforests. However, major urban and rural areas have been involved in the most recent outbreak in western Africa.
Early supportive care, which includes rehydration and symptomatic treatment, improves the survival rate. No licensed treatment has yet been proven to be able to neutralize the virus but a number of blood, immunological and drug medications are under development. There are no licensed Ebola vaccines yet but two candidates are being evaluated.